Professor of Pharmaceutical Biology at the Department of Biomedical, Surgical and Dental Sciences, Faculty of Medicine, University of Milan. He has been studying bioactive phytochemicals, nutraceuticals, functional foods, phytonutrients, phytotherapeutics, botanicals and essential oils relevant for human and animal nutrition and health, focusing on their functional role in planta as well as on their preclinical (in vitro/in vivo) and in human biological/pharmacological activities. He has been investigating the effects of elicitors on plant secondary metabolism, as an approach to obtain phytochemical-enriched plant foods and medicinal herbs. He has been studying the health-promoting effects of the traditional Mediterranean diet as well as the ethnopharmacology of herbal remedies and traditional healing systems.
Author of more than 330 publications with IF (Scopus h-index: 62).
- Top 2% Scientists since 2020 to 2023, List of Outstanding Researchers by Stanford University, USA
(https://topresearcherslist.com/Home/Profile/576280).
- World’s Best Biology and Biochemistry Scientist (https://research.com/u/marcello-iriti).
- Top Cited Scholar 2023-2024 (https://www.scilit.net/scholars/8478802).
- Top Italian Scientist (https://topitalianscientists.org/tis/54235/Marcello_Iriti_-_Top_Italian_Scientist_in_Biomedical_Sciences).
- Top Author University of Milan
(https://www.scival.com/overview/authors/topAuthorsByScholarlyOutput?uri=Institution/321055).
Founding Member and Member of the Scientific Committee of the Italian Society of Environmental Medicine (SIMA); Member of the Natural Products Research Academy (NPRA) (www.npracademy.com); Member of the Academic Society for Functional Foods & Bioactive Compounds (ASFFBC); Member of the Working Group ‘Pharmacognosy, Phytotherapy and Nutraceuticals’, Italian Pharmacological Society; Member of the Italian Society of Phytotherapy; Member of the Italian Society of Phytochemistry; Member of the Mediterranean Nutrition Science Academy; Member of the and Asian Council of Science Editors.
Main Patent: ‘Compositions Comprising Rutin Useful for the Treatment of Tumors Resistant to Chemotherapy’ (WO2015036875A1; US20160213698; US9757405B2; EP3043821).
Professional Profiles
https://orcid.org/0000-0002-5063-1236
https://www.scopus.com/authid/detail.uri?authorId=6506548774
